The Market Reports

Synopsis
The global market for Ventricular Assist Device was estimated to be worth US$ 1546 million in 2024 and is forecast to a readjusted size of US$ 2651 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts. A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.
Market Driver: The growing prevalence of heart failure and cardiovascular diseases is a key driver for the Ventricular Assist Device (VAD) market. As the global aging population increases, so does the number of patients suffering from end-stage heart failure, leading to a higher demand for VADs as both a bridge-to-transplant and destination therapy. Additionally, advancements in VAD technology, such as smaller, more durable, and biocompatible devices with reduced complications, have improved patient outcomes and expanded the adoption of these devices. Government initiatives, increasing healthcare expenditures, and rising awareness of mechanical circulatory support systems further fuel market growth.
Market Challenge: Despite its growth, the VAD market faces significant challenges, primarily related to high costs and surgical risks. The implantation procedure for VADs is complex, requiring skilled surgeons and advanced medical infrastructure, which limits accessibility, especially in developing regions. Moreover, post-implantation complications, such as infections, thromboembolism, and device malfunction, remain concerns, necessitating continuous monitoring and long-term patient management. Regulatory hurdles and reimbursement limitations in certain countries also pose barriers to widespread adoption, slowing market expansion.
This report aims to provide a comprehensive presentation of the global market for Ventricular Assist Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ventricular Assist Device by region & country, by Type, and by Application.
The Ventricular Assist Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ventricular Assist Device.
Market Segmentation
By Company
AbioMed
Abbott (Thoratec)
Medtronic (HeartWare)
Berlin Heart
Evaheart
CH Biomedical
ROCOR Medical
coretech medical
BiVACOR
CorWave
Segment by Type
LVADs
RVADs
BIVADs
Segment by Application
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ventricular Assist Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ventricular Assist Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ventricular Assist Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index